查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1876645

免疫調節蛋白水解物市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Immunomodulatory Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球免疫調節蛋白水解物市值為 7.09 億美元，預計到 2034 年將以 6.3% 的複合年成長率成長至 13 億美元。

免疫調節蛋白水解物市場 - IMG1

隨著消費者對免疫健康的日益關注以及對免疫相關疾病的深入了解，該行業正經歷強勁的發展勢頭。這些水解物是透過酶促反應將蛋白質轉化為短鏈生物活性胜肽而製成的，它們在調節免疫活性方面發揮積極作用，既能支持防禦反應，又能緩解發炎。由於它們能夠增強免疫力、降低感染風險並促進康復，因此其價值涵蓋功能性食品、膳食補充劑和藥物製劑。此外，它們的高生物利用度、安全性、針對性的免疫益處以及極低的副作用也推動了市場需求。消費者對天然和功能性成分日益成長的興趣持續推動著這些產品的普及，而個人化營養和預防保健的興起也帶來了巨大的市場機會。老年人口的成長及其面臨的更高免疫風險進一步促進了市場的發展。專注於開發具有增強免疫調節潛力的新型胜肽的研究工作不斷刺激著產品創新，食品、飲料和治療領域的製造商正在將這些成分應用於各種配方中，包括那些在臨床環境中用於免疫支持的研究。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 7.09億美元
預測值 13億美元
複合年成長率 6.3%

由於強大的科學支持、成熟的生產能力以及長期以來公認的免疫調節功能，乳基水解物在2024年佔據了61.5%的市場。主要的乳製品生產商已投資於先進的酶法工藝，以提供穩定、高品質且具有可靠生物活性的水解物。

2024年，臨床和醫學營養品市場佔有率預計將達到21%，這主要得益於市場對免疫力低下或有特殊醫療需求人群的客製化解決方案的需求。此細分市場包括為接受強化治療的患者、免疫力下降的老年人以及自體免疫疾病患者設計的營養方案。

北美免疫調節蛋白水解物市場佔據42.1%的市場佔有率，預計到2034年將以6.4%的複合年成長率成長，這主要得益於消費者對功能性營養品的強勁接受度以及完善的創新環境。該地區的企業正投入大量資源進行研發，致力於開發具有更強免疫支持特性的新一代水解物。

全球免疫調節蛋白水解物市場的主要參與者包括Arla Foods Ingredients、Azelis Group、Cargill, Incorporated、DSM-Firmenich、Fonterra (NZMP)、FrieslandCampina Ingredients、Glanbia PLC、Hilmar Cheese Company, Inc.、Kerry Group、PB Leiner、RoquetteTatua。這些企業正採取多項策略性舉措，以增強其競爭優勢。許多企業優先投資酵素技術，以提高產品的一致性、純度和生物活性。此外，各公司也正在拓展合作研究項目，以發現新的胜肽功能並加速臨床驗證。透過開發針對特定消費群體（包括老年人群和具有特定免疫需求的人群）的客製化水解物，各企業正在不斷豐富其產品組合。同時，各企業也加強供應鏈建設，以確保可靠的採購和高效的全球分銷。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

  • 產業生態系分析
    • 供應商格局
    • 利潤率
    • 每個階段的價值增加
    • 影響價值鏈的因素
    • 中斷
  • 產業影響因素
    • 成長促進因素
    • 產業陷阱與挑戰
    • 市場機遇
  • 成長潛力分析
  • 監管環境
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特的分析
  • PESTEL 分析
  • 價格趨勢
    • 按地區
    • 按產品類別
  • 未來市場趨勢
  • 技術與創新格局
    • 當前技術趨勢
    • 新興技術
  • 專利格局
  • 貿易統計（HS編碼）（註：僅提供重點國家的貿易統計資料）
    • 主要進口國
    • 主要出口國
  • 永續性和環境方面
    • 永續實踐
    • 減少廢棄物策略
    • 生產中的能源效率
    • 環保舉措
  • 碳足跡考量

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • MEA
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 關鍵進展
    • 併購
    • 合作夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章：市場估算與預測：依產品分類，2021-2034年

  • 主要趨勢
  • 乳源蛋白水解物
    • 乳清蛋白水解物
    • 酪蛋白水解物
    • 乳鐵蛋白水解物
  • 植物源蛋白水解物
    • 大豆蛋白水解物
    • 米蛋白水解物
    • 豌豆蛋白水解物
    • 其他
  • 海洋來源蛋白質水解物
    • 魚蛋白水解物
    • 藻類和微藻水解物
    • 海洋無脊椎動物水解物
  • 動物源性蛋白質水解物
    • 蛋清蛋白水解物
    • 肉類蛋白水解物
    • 膠原蛋白水解物
  • 其他來源水解物
    • 昆蟲蛋白質水解物
    • 微生物蛋白水解物
    • 單細胞蛋白水解物

第6章：市場估算與預測：依應用領域分類，2021-2034年

  • 主要趨勢
  • 運動營養應用
    • 運動前免疫支持
    • 運動後恢復和抗發炎
    • 耐力運動應用
  • 臨床/醫學營養應用
    • 免疫功能低下患者的支持
    • 癌症治療輔助劑
    • 自體免疫疾病管理
    • 傷口癒合與組織修復
  • 嬰兒營養應用
    • 低致敏配方研發
    • 免疫系統發育支持
    • 早產兒特殊營養
  • 功能性食品和飲料
    • 增強免疫力的飲料
    • 功能性乳製品
    • 烘焙和零食應用
  • 藥物應用
    • 藥物輸送系統
    • 免疫療法組合
    • 疫苗佐劑

第7章：市場估算與預測：依加工方式分類，2021-2034年

  • 關鍵趨勢
  • 酵素水解
  • 酸/鹼水解
  • 發酵衍生的水解物
  • 先進處理技術

第8章：市場估算與預測：依地區分類，2021-2034年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第9章：公司簡介

  • Arla Foods Ingredients
  • Azelis Group
  • Cargill
  • DSM-Firmenich
  • Fonterra (NZMP)
  • FrieslandCampina Ingredients
  • Glanbia PLC
  • Hilmar Cheese Company, Inc.
  • Kerry Group
  • PB Leiner
  • Roquette
  • Tatua
簡介目錄
Product Code: 15214

The Global Immunomodulatory Protein Hydrolysates Market was valued at USD 709 million in 2024 and is estimated to grow at a CAGR of 6.3% to reach USD 1.3 billion by 2034.

Immunomodulatory Protein Hydrolysates Market - IMG1

The industry is experiencing strong momentum as consumers become more aware of immune health and gain a clearer understanding of immune-related conditions. These hydrolysates, created by enzymatically converting proteins into short, bioactive peptides, play an active role in helping regulate immune activity by either supporting defensive responses or moderating inflammation. Their value spans functional foods, dietary supplements, and pharmaceutical formulations because they promote immune resilience, help reduce vulnerability to infections, and contribute to recovery processes. Demand is also shaped by their high bioavailability, safety profile, targeted immune benefits, and minimal side effects. Rising interest in natural and functional ingredients continues to elevate adoption, while the growth of personalized nutrition and preventive wellness adds substantial opportunity. An expanding older population that faces higher immune risks is further contributing to market progression. Research efforts focusing on new peptides with enhanced immunomodulatory potential continue to stimulate product innovation, and manufacturers across food, beverage, and therapeutic categories are incorporating these ingredients into a wide range of formulations, including those explored for immune support in clinical settings.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$709 Million
Forecast Value$1.3 Billion
CAGR6.3%

The milk-based hydrolysates segment held 61.5% share in 2024 owing to strong scientific support, established production capabilities, and long-recognized immune modulation functions. Major dairy-linked producers have invested in advanced enzymatic processes to deliver consistent, high-quality hydrolysates with reliable bioactive characteristics.

The clinical and medical nutrition segment held a 21% share in 2024, driven by demand for specialized solutions tailored to individuals with compromised immunity or unique medical requirements. This segment includes nutritionally designed options for people undergoing intensive treatments, older adults with age-related immune decline, and individuals managing autoimmune-related challenges.

North America Immunomodulatory Protein Hydrolysates Market held 42.1% share and is projected to grow at a 6.4% CAGR through 2034, supported by strong consumer acceptance of functional nutrition and a well-developed innovation environment. Companies in the region are devoting substantial resources to research geared toward developing next-generation hydrolysates with enhanced immune-support properties.

Prominent companies participating in the Global Immunomodulatory Protein Hydrolysates Market include Arla Foods Ingredients, Azelis Group, Cargill, Incorporated, DSM-Firmenich, Fonterra (NZMP), FrieslandCampina Ingredients, Glanbia PLC, Hilmar Cheese Company, Inc., Kerry Group, PB Leiner, Roquette, and Tatua. Companies in the Immunomodulatory Protein Hydrolysates Market are pursuing several strategic actions to secure a stronger competitive position. Many are prioritizing large-scale investment in enzymatic technology to improve consistency, purity, and bioactivity. Firms are also expanding collaborative research programs to identify new peptide functionalities and accelerate clinical validation. Product portfolios are widening through the development of tailored hydrolysates designed for specific consumer groups, including aging populations and individuals with targeted immune needs. Businesses are reinforcing supply chains to ensure reliable sourcing and efficient global distribution.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product
    • 2.2.3 Application
    • 2.2.4 Processing method
  • 2.3 TAM Analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By product category
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Product, 2021-2034 (USD Million & Kilo Tons)

  • 5.1 Key trends
  • 5.2 Milk-derived protein hydrolysates
    • 5.2.1 Whey protein hydrolysates
    • 5.2.2 Casein protein hydrolysates
    • 5.2.3 Lactoferrin hydrolysates
  • 5.3 Plant-derived protein hydrolysates
    • 5.3.1 Soy protein hydrolysates
    • 5.3.2 Rice protein hydrolysates
    • 5.3.3 Pea protein hydrolysates
    • 5.3.4 Others
  • 5.4 Marine-derived protein hydrolysates
    • 5.4.1 Fish protein hydrolysates
    • 5.4.2 Algae & microalgae hydrolysates
    • 5.4.3 Marine invertebrate hydrolysates
  • 5.5 Animal-derived protein hydrolysates
    • 5.5.1 Egg protein hydrolysates
    • 5.5.2 Meat protein hydrolysates
    • 5.5.3 Collagen hydrolysates
  • 5.6 Other source hydrolysates
    • 5.6.1 Insect protein hydrolysates
    • 5.6.2 Microbial protein hydrolysates
    • 5.6.3 Single-cell protein hydrolysates

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 (USD Million & Kilo Tons)

  • 6.1 Key trends
  • 6.2 Sports nutrition applications
    • 6.2.1 Pre-workout immune support
    • 6.2.2 Post-exercise recovery & anti-inflammatory
    • 6.2.3 Endurance sports applications
  • 6.3 Clinical/medical nutrition applications
    • 6.3.1 Immunocompromised patient support
    • 6.3.2 Cancer therapy adjuvants
    • 6.3.3 Autoimmune disease management
    • 6.3.4 Wound healing & tissue repair
  • 6.4 Infant nutrition applications
    • 6.4.1 Hypoallergenic formula development
    • 6.4.2 Immune system development support
    • 6.4.3 Preterm infant specialized nutrition
  • 6.5 Functional foods & beverages
    • 6.5.1 Immune-boosting beverages
    • 6.5.2 Functional dairy products
    • 6.5.3 Bakery & snack applications
  • 6.6 Pharmaceutical applications
    • 6.6.1 Drug delivery systems
    • 6.6.2 Immunotherapy combinations
    • 6.6.3 Vaccine adjuvants

Chapter 7 Market Estimates and Forecast, By Processing Method, 2021-2034 (USD Million & Kilo Tons)

  • 7.1 Key trend
  • 7.2 Enzymatic hydrolysis
  • 7.3 Acid/alkaline hydrolysis
  • 7.4 Fermentation-derived hydrolysates
  • 7.5 Advanced processing technologies

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 (USD Million & Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Arla Foods Ingredients
  • 9.2 Azelis Group
  • 9.3 Cargill
  • 9.4 DSM-Firmenich
  • 9.5 Fonterra (NZMP)
  • 9.6 FrieslandCampina Ingredients
  • 9.7 Glanbia PLC
  • 9.8 Hilmar Cheese Company, Inc.
  • 9.9 Kerry Group
  • 9.10 PB Leiner
  • 9.11 Roquette
  • 9.12 Tatua